Two‐year follow‐up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study

Documents similaires

• Chronic inflammation in benign prostatic hyperplasia: Pathophysiology and treatment options
  par: So Inamura, et autres
  Publié: (2024)
• Editorial Comment on “Initial outcomes and surgical techniques of prostatic urethral lift for benign prostatic hyperplasia in Japan”
  par: Takafumi Yagisawa, et autres
  Publié: (2024)
• Quality of life and influencing factors in older adults with benign prostatic hyperplasia
  par: Chen‐ke Wang, et autres
  Publié: (2024)
• Evaluation of learning curves for contact laser vaporization of the prostate using the 980 nm diode laser for benign prostatic hyperplasia
  par: Jun Furumido, et autres
  Publié: (2024)
• HoLEP: a platinum standard for modern benign prostatic hyperplasia treatment
  par: Edward J Bass, et autres
  Publié: (2024)